Immune Checkpoint Inhibitors in Head and Neck Cancer: Summary of Key Points for Practice

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered malignancies.

Alexander Drilon, MD
Program Director Thomas Stinchcombe, MD
Program Director Released: August 4, 2022

Downloadable slideset on therapies for previously treated advanced HER2-negative gastric/GEJ cancers, from Clinical Care Options (CCO)

Samuel Klempner, MD Released: July 21, 2022

Downloadable slideset on therapies for untreated advanced HER2-negative gastric/GEJ cancers, from Clinical Care Options (CCO)

Yelena Y. Janjigian, MD Released: July 21, 2022

Commentary on evolving treatment paradigms in gynecologic cancers, from Clinical Care Options (CCO)

David Scott Miller, MD, FACOG, FACS
Program Director Nicoletta Colombo, MD Shannon N. Westin, MD, MPH Released: July 14, 2022